A balloon catheter capable of directional drug release
Through the design of split-flap balloons and multi-cavity structure of the catheter, combined with the improvement of balloon material, the directional release of the drug balloon catheter is achieved, which solves the problems of limited drug loading and undirected release of the drug balloon catheter and improves the drug utilization rate and therapeutic effects.
Patent Information
- Application Number
- CN202010104533.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-02-20
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2040-02-20
AI Technical Summary
The existing drug balloon catheters have a limited loading volume due to uniform materials and limited loading methods, and the drug release is not directional enough when dilating in the blood vessels, resulting in drug loss and poor treatment effect.
The balloon design is adopted, and the balloon flap is combined with the catheter. Through the multi-cavity structure of the catheter and the balloon material, a drug-loading groove and marking line are formed to achieve directional release and efficient utilization of drugs.
It significantly improves the drug load and treatment accuracy, reduces drug loss, improves the utilization rate and therapeutic effect of drugs, and has clinical application value.
Smart Images

Figure CN111110991B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of drug balloon catheters, and in particular to a balloon catheter capable of directionally releasing drugs. Background Art
[0002] Vascular stenosis is one of the important causes of myocardial infarction, stroke and other diseases, and poses a huge threat to human life and health. For a long time, through the unremitting efforts of medical workers, several solutions have gradually been formed for vascular stenosis, including drug treatment, stent implantation, balloon catheter interventional dilatation and angioplasty.
[0003] Balloon catheter interventional dilatation and angioplasty acts directly on the stenotic lesions, instantly restoring vascular patency without the need for subsequent large amounts of medication, and avoids the potential risks that implants bring to patients. However, after the blood vessels are dilated by a balloon catheter, there is still a high chance of re-narrowing, so drug-eluting balloon catheters came into being.
[0004] Drug-eluting balloon catheters are balloon catheters with drugs such as paclitaxel, rapamycin, and probucol on the surface for treating vascular stenosis and preventing restenosis. The drug-eluting balloon reaches the stenotic lesion, is pressurized and filled, and releases drugs to the lesion while expanding the blood vessel, thereby achieving the purpose of treating stenosis and preventing restenosis.
[0005] The existing drug balloon catheters usually have a balloon made of uniform material, which takes a relatively regular spherical or ellipsoidal shape after being filled. The drug is usually loaded by surface spraying, so the drug loading amount is generally limited. At the same time, due to the irregularity of the inner wall of the stenotic blood vessel, when the drug balloon catheter dilates the blood vessel, the part of the balloon that contacts the stenotic lesion accounts for a small proportion of the balloon surface area, and most of the balloon surface contacts the non-lesion blood vessel wall, which will inevitably cause drug loss.
[0006] Therefore, technicians in this field are committed to developing a balloon catheter that can release drugs in a directed manner. The multi-lumen structure of the catheter, combined with a special balloon marking method, allows the balloon to be adjusted according to the location and direction of the lesion in actual use, thereby improving the maneuverability of the balloon catheter. By improving the balloon structure and adopting a petal-type balloon design, a drug-loading groove is formed on the balloon surface, which significantly increases the drug loading capacity of the balloon. At the same time, by improving the balloon material, the directed release of drugs to narrow lesions is achieved, thereby avoiding unnecessary losses, improving the utilization rate of drugs and the accuracy of treatment, and having clinical application value. Summary of the invention
[0007] In view of the above-mentioned defects of the prior art, the technical problem to be solved by the present invention is to develop a balloon catheter capable of directionally releasing drugs, and to improve the utilization rate of drugs and the therapeutic effect by improving the balloon structure, the catheter structure and the balloon material.
[0008] To achieve the above-mentioned purpose, the present invention provides a balloon catheter capable of directionally releasing drugs, characterized in that it comprises a balloon, a catheter and a handle, wherein the catheter has an axial hollow cavity, the balloon is close to the first end of the catheter, and the handle is located at the second end of the catheter; the balloon is a valve structure, comprising a first balloon valve and a second balloon valve, wherein the first balloon valve is loaded with drugs, and the second balloon valve is not loaded with drugs or has drugs sprayed on its surface; the handle can be connected to a liquid pump or an air pump.
[0009] Furthermore, the first balloon valve and the second balloon valve are independent of each other and are spliced together to form the balloon.
[0010] Furthermore, the first balloon valve and the second balloon valve are made of balloon materials with different compliances.
[0011] Furthermore, there is a height difference and a shape difference between the first balloon valve and the second balloon valve, thereby forming a groove on the balloon surface.
[0012] Furthermore, the first end of the conduit is tapered.
[0013] Furthermore, the catheter is a multi-lumen tube with a single-layer tube wall, and a channel is provided inside the catheter wall, which is connected from the second end of the catheter to the inside of the balloon valve.
[0014] Furthermore, within the effective length of the balloon, there are marking lines of different lengths and discontinuities passing through the center of the communication opening between the channel and the balloon valve.
[0015] Furthermore, the marking line is a platinum-iridium alloy or other material that does not project a line, and the marking line is embedded in the catheter wall or attached to the catheter surface.
[0016] Furthermore, there is a corresponding relationship between the hole and the balloon valve, and there is a corresponding relationship between the balloon valve and the marking line.
[0017] Furthermore, the second balloon valve can establish a drug release channel when inflated.
[0018] The balloon catheter of the present invention has the following technical effects:
[0019] 1. By improving the balloon structure and adopting a split-petal balloon design, drug-loading grooves are formed on the balloon surface, which significantly increases the drug loading capacity of the balloon;
[0020] 2. The multi-lumen structure of the catheter, combined with a special balloon marking method, allows the balloon to be adjusted according to the location and direction of the lesion in actual application, thus improving the maneuverability of the balloon catheter;
[0021] 3. By improving the balloon material, the drug can be released in a targeted manner to narrow lesions, thus avoiding unnecessary losses, improving the drug utilization rate and therapeutic effect, and having clinical application value.
[0022] The concept, specific structure and technical effects of the present invention will be further described below in conjunction with the accompanying drawings to fully understand the purpose, characteristics and effects of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 It is an overall schematic diagram of a preferred embodiment of the present invention;
[0024] Figure 2 is a schematic cross-sectional view of a balloon of a preferred embodiment of the present invention when it is not inflated;
[0025] Figure 3 is a schematic side cross-sectional view of a catheter of a preferred embodiment of the present invention;
[0026] Figure 4 is a schematic cross-sectional view of a catheter of a preferred embodiment of the present invention;
[0027] Figure 5 It is a schematic diagram of a marking method of a balloon valve according to a preferred embodiment of the present invention;
[0028] Figure 6 This is a schematic diagram of the operation of filling a balloon valve with medicine according to a preferred embodiment of the present invention;
[0029] Figure 7 It is a schematic cross-sectional view of another preferred embodiment of the present invention when the balloon is not inflated. DETAILED DESCRIPTION
[0030] The following describes several preferred embodiments of the present invention with reference to the drawings in the specification, so that the technical content is clearer and easier to understand. The present invention can be embodied in many different forms of embodiments, and the protection scope of the present invention is not limited to the embodiments mentioned in the text.
[0031] In the drawings, components with the same structure are indicated by the same numerical reference numerals, and components with similar structures or functions are indicated by similar numerical reference numerals. The size and thickness of each component shown in the drawings are arbitrarily shown, and the present invention does not limit the size and thickness of each component. In order to make the illustration clearer, the thickness of the components is appropriately exaggerated in some places in the drawings.
[0032] Embodiment 1
[0033] like Figure 1, which is a schematic diagram of a balloon catheter capable of directional drug release, and is mainly composed of a balloon 1, a catheter 2, and a handle 3. The balloon 1 is a flap structure, the balloon flap 11 is loaded with drugs, and the balloon flap 12 is not loaded with drugs or is sprayed with drugs on the surface. In this article, the balloon flap 11 and the balloon flap 12 represent a type of balloon flap, rather than a specific balloon flap in the schematic diagram.
[0034] The catheter 2 has an axial hollow cavity 23, and the catheter 2 can be connected to the balloon 1 through a guide wire or other instruments. The end of the catheter 1 adjacent to the balloon 1 is called the distal end 21, and the end of the catheter 1 adjacent to the handle 3 is called the proximal end 22. The distal end 21 of the catheter 1 is tapered to fit closely with the guide wire to prevent scratching of the blood vessel. The handle 3 can be connected to a liquid pump or an air pump, and its style is not limited to that shown in the figure.
[0035] like Figure 2 The figure shows a cross-sectional view of the balloon 1 when it is not filled. The balloon valve 11 and the balloon valve 12 are made of balloon materials with different compliances. The balloon valve 11 and the balloon valve 12 are independent of each other, that is, the balloon material constituting the balloon valve 11 and the balloon material constituting the balloon valve 12 are separated from each other and spliced together to form the balloon 1; the balloon valve 11 and the balloon valve 12 have certain height and shape differences, thereby forming a groove on the balloon surface, which can be filled with a large amount of medicine 13. In the figure, 24 is the catheter wall, and 14 is the channel inside the balloon valve (11 or 12).
[0036] like Figure 3 The catheter 2 is a multi-lumen tube with a single-layer wall, and the inner wall 24 of the catheter has a channel 14 connected from the proximal end of the catheter to the inner part of the balloon 1 .
[0037] like Figure 4 , which is a schematic cross-sectional view of the proximal end of the catheter. The channel 14 runs through the catheter wall 24 and is connected to the balloon valve. Liquid or gas is injected into the channel 14 to fill the balloon valve.
[0038] There is a corresponding relationship between the holes at different positions on the cross section of the proximal end of the catheter and the balloon valve. The holes are marked and liquid or gas is injected into the holes at specific positions to achieve filling of the specific balloon valve.
[0039] like Figure 5 As shown in FIG. 1 , it is a schematic diagram of a marking method for a balloon, i.e., a balloon valve. Within the effective length of the balloon, there are marking lines 26 of different lengths and discontinuities passing through the center of the connecting opening 25 between the channel and the balloon valve. The marking line points can be made of platinum-iridium alloy or other materials that do not project lines. The marking lines are embedded in the catheter wall or attached to the catheter surface. The marking method of the balloon valve is not limited to that shown in the figure.
[0040] There is a corresponding relationship between the hole on the cross section of the proximal end of the catheter and the balloon valve, and there is a corresponding relationship between the balloon valve and the marking line. In clinical surgery, the location of the stenotic lesion corresponds to a certain marking line. If the marking line corresponds to the drug-loaded balloon valve, liquid or gas is injected into the corresponding hole to fill the balloon valve, which can achieve the purpose of directional release of drugs; if the marking point corresponds to a non-drug-loaded balloon valve, the drug-loaded balloon valve can be aligned with the stenotic lesion by properly rotating the balloon catheter, and then the balloon is filled to release the drug in a directional manner.
[0041] Embodiment 2
[0042] like Figure 6 In order to improve the utilization efficiency of the drug and avoid drug loss, when releasing the drug in a targeted manner, the non-drug-loaded balloon valve 12 can be filled first to establish the drug release channel 15, and then the drug-loaded balloon valve 11 can be filled.
[0043] Embodiment 3
[0044] like Figure 3 As shown, the balloon flap 11 and the balloon flap 12 are made of the same balloon material, but the thickness and uniformity of the balloon material used by the balloon flap 11 and the balloon flap 12 are different, so the compliance is different. At this time, the balloon material constituting the balloon flap 11 and the balloon material constituting the balloon flap 12 are independent units separated from each other, that is, the balloon flap 11 and the balloon flap 12 are independent units separated from each other, and the balloon flap 11 and the balloon flap 12 are spliced or otherwise formed into a balloon 1; there are certain differences in height and shape between the balloon flap 11 and the balloon flap 12, thereby forming a groove on the balloon surface, which can be filled with a larger amount of drug 13.
[0045] Embodiment 4
[0046] like Figure 3 As shown, the balloon material of the balloon flap 11 and the balloon flap 12 is the same, and the balloon material constituting the balloon flap 11 and the balloon material constituting the balloon flap 12 belong to a whole, but there are differences in thickness and uniformity, and thus different compliances, that is, the balloon flap 11 and the balloon flap 12 are both part of the balloon 1, and the balloon 1 forms the balloon flap 11 and the balloon flap 12 by folding or other means. There are certain differences in height and shape between the balloon flap 11 and the balloon flap 12, so that a groove is formed on the surface of the balloon, which can be filled with a larger amount of medicine 13.
[0047] Embodiment 5
[0048] like Figure 7 As shown, the balloon flap 11 and the balloon flap 12 are made of the same balloon material, but the balloon flap 11 is folded or otherwise different from the balloon flap 12 in height and shape, thereby forming a groove on the balloon surface, which can be filled with a larger amount of drug 13.
[0049] Embodiment 6
[0050] Two or more of the above-mentioned embodiments three, four and five may be used simultaneously to achieve the difference in height and shape between the balloon valve 11 and the balloon 12, thereby forming a groove on the balloon surface to facilitate loading of a larger amount of medicine.
[0051] Embodiment 7
[0052] The balloon 1 is composed of three or more different types of balloon valves, and adopts one or more solutions in Embodiments 1 to 5.
[0053] Embodiment 8
[0054] One or more of the schemes in Example 1 to Example 7 are adopted to embed the radiopaque material as a marker into the polymer material constituting the balloon valve, or the balloon valve is marked by other means.
[0055] The preferred specific embodiments of the present invention are described in detail above. It should be understood that ordinary technicians in the field can make many modifications and changes based on the concept of the present invention without creative work. Therefore, all technical solutions that can be obtained by technicians in the technical field based on the concept of the present invention through logical analysis, reasoning or limited experiments on the basis of the prior art should be within the scope of protection determined by the claims.
Claims
1. A balloon catheter capable of directional drug release, characterized in that: It comprises a balloon, a catheter and a handle, wherein the catheter has an axial hollow cavity, the balloon is close to the first end of the catheter, and the handle is located at the second end of the catheter; the balloon is a valve structure, comprising a first balloon valve and a second balloon valve, wherein the first balloon valve is loaded with medicine, and the second balloon valve is not loaded with medicine or has medicine sprayed on its surface; the handle can be connected to a liquid pump or an air pump; The first balloon flap and the second balloon flap are independent of each other and are spliced together to form the balloon; The first balloon valve and the second balloon valve are made of balloon materials with different compliances; There is a height difference and a shape difference between the first balloon valve and the second balloon valve, thereby forming a groove on the balloon surface.
2. The balloon catheter capable of directional drug release according to claim 1, characterized in that: The first end of the conduit is tapered.
3. The balloon catheter capable of directional drug release according to claim 1, characterized in that: The catheter is a multi-lumen tube with a single-layer tube wall, and a channel is provided inside the catheter wall, which is connected from the second end of the catheter to the inside of the balloon valve.
4. The balloon catheter capable of directional drug release according to claim 3, characterized in that: Within the effective length of the balloon, there are marking lines of different lengths and discontinuities passing through the center of the communication opening between the channel and the balloon valve.
5. The balloon catheter capable of directional drug release according to claim 4, characterized in that: The marking line is a platinum-iridium alloy and is embedded in the catheter wall or attached to the catheter surface.
6. The balloon catheter capable of directional drug release according to claim 5, characterized in that: There is a corresponding relationship between the hole and the balloon valve, and there is a corresponding relationship between the balloon valve and the marking line.
7. The balloon catheter capable of directional drug release according to claim 1, characterized in that: The second balloon valve can establish a drug release channel when inflated.
